- Target
- Villin
- Reactivity
- Human,Mouse,Pig,Bovine
- Application
- IHC
- MW(Calculated)
- --
- MW(Observed)
- --
- Host Species
- Rabbit
- Isotype
- IgG1,Kappa
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- --
- Form
- Ready to use for IHC
- Source
- The prediluted ready-to-use antibody is diluted in phosphate buffer saline containing stabilizing protein and 0.05% Proclin 300
- Purification
- --
- Purity
- --
- storageCondition
- 2°C to 8°C/1 year,Ship by ice bag
- Concentration
- --
- Clonality
- Monoclonal
- Clone No.
- PT0094R
- Immunogen
- Synthesized peptide derived from human Villin AA range:150-250
- Sequence
- --
- Specificity
- Endogenous
- Gene Name
- VIL1 VIL
- Protein Name
- Villin-1
- Other Name
- D2S1471;OTTHUMP00000164145;VIL;VIL1;VILI_HUMAN;Villin 1;Villin-1;Villin1
- Organism-1
- Human
- Gene ID-1
- 7429
- SwissProt-1
- P09327
- Organism-2
- --
- Gene ID-2
- --
- SwissProt-2
- --
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasm, cytoskeleton. Cell projection, lamellipodium. Cell projection, ruffle. Cell projection, microvillus. Cell projection, filopodium tip . Cell projection, filopodium . Relocalized in the tip of cellular protrusions and filipodial extensions upon infection with S.flexneri in primary intestinal epithelial cells (IEC) and in the tail-like structures forming the actin comets of S.flexneri. Redistributed to the leading edge of hepatocyte growth factor (HGF)-induced lamellipodia (By similarity). Rapidly redistributed to ruffles and lamellipodia structures in response to autotaxin, lysophosphatidic acid (LPA) and epidermal growth factor (EGF) treatment. .